CTLA-4 CT-60 A/G and CTLA-4 1822 C/T Gene Polymorphisms in Indonesians with Type 1 Diabetes Mellitus

Nur Rochmah, - and Muhammad Faizi, - and Suhasta Nova, - and Retno Asih Setyoningrum, - and Sukmawati Basuki, - and Anang Endaryanto, - (2022) CTLA-4 CT-60 A/G and CTLA-4 1822 C/T Gene Polymorphisms in Indonesians with Type 1 Diabetes Mellitus. The Application of Clinical Genetics, 2022 (15). pp. 19-25. ISSN 1178-704X

This is the latest version of this item.

[img] Text (Artikel)
4 - Artikel.pdf

Download (2MB)
[img] Text (Kualitas Karil)
4 - Kualitas Karil.pdf

Download (256kB)
[img] Text (Turnitin)
4 - Turnitin.pdf

Download (1MB)
[img] Text (Korespondensi)
4 - Korespondensi.pdf

Download (1MB)
[img] Text (Karil dr M Faizi (C -19))
Karil - CTLA-4 CT-60 AG and CTLA-4 1822 CT Gene Polymorphisms in Indonesians with Type 1 Diabetes Mellitus.pdf

Download (267kB)
Official URL: https://www.dovepress.com/ctla-4-ct-60-ag-and-ctla...

Abstract

Introduction: CTLA-4 gene polymorphism plays an important role in children with type 1 diabetes mellitus (T1DM). However, data on this subject vary among different races and ethnics. Purpose: To analyze CTLA-4 CT-60 A/G and CTLA-4 1822 C/T gene polymorphism among children with T1DM compared to control. Patients and Methods: The CTLA-4 CT-60 A/G and CTLA-4 1822 C/T gene polymorphism in children with T1DM using polymerase chain reaction-restriction fragment length polymorphism in 25 T1DM and 25 controls. The inclusion criteria were patients regularly controlled at the Pediatric Endocrine Outpatient Clinic of Dr. Soetomo Hospital, aged 4–18 years and willing to join this study and the exclusion criteria were T1DM patients hospitalized in the pediatric intensive care unit. In the control group, the inclusion criteria were healthy children, aged 4–18 years and willing to join this study. The exclusion criteria included children with ongoing infection, history of other autoimmune diseases, allergies, or malignancy. Results: The mean age was 12.48 years old, and the mean of T1DM onset was 9.28 years old. The CTLA-4 1822 T allele observed in 62% T1DM and 56% in control (p = 0.388, OR = 0.78, 95% CI = 0.44–1.37) and CTLA-4 CT-60 G allele observed in 52% T1DM and 58% in control (p = 0.393, OR = 1.27, 95% CI = 0.73–2.22). The C/T genotypes was significantly higher in control group (p = 0.045, OR = 3.27, 95% CI = 1.00–10.62). The A/G genotypes was commonly found in control group (p = 0.765, OR = 1.20, 95% CI = 0.37– 3.86). The Javanese was the dominant ethnic group in our study. Conclusion: The frequency of CTLA-4 CT-60 A/G polymorphism almost equivalent in T1DM and control group. However, CTLA-4 1822 C/T polymorphism was more prevalent in the control group; thus, this genotype may have a protective effect against T1DM.

Item Type: Article
Uncontrolled Keywords: type 1 diabetes mellitus, CTLA-4
Subjects: R Medicine > R Medicine (General)
R Medicine > RJ Pediatrics
Divisions: 01. Fakultas Kedokteran > Ilmu Kesehatan Anak (Sub Spesialis)
Creators:
CreatorsNIM
Nur Rochmah, -NIDN0029047909
Muhammad Faizi, -NIDN8890900016
Suhasta Nova, -UNSPECIFIED
Retno Asih Setyoningrum, -NIDN0026037102
Sukmawati Basuki, -NIDN0005026503
Anang Endaryanto, -NIDN8867700016
Depositing User: Mrs Elok Dian Nuraeni
Date Deposited: 30 May 2023 22:29
Last Modified: 30 May 2023 22:29
URI: http://repository.unair.ac.id/id/eprint/126880
Sosial Share:

Available Versions of this Item

Actions (login required)

View Item View Item